“We have evidence that warnings were ignored and that these products continued to be used despite the warnings and that following the infections…[there was] a cover-up,” – Andy Evans, chairman of campaign group Tainted Blood
These quotations from today’s news refer not to the Deprox, but to the tragic suffering and loss of life from infected blood administered by the NHS in the 70s and 80s. At last, there is to be an inquiry, and the victims’ relatives will know how and why 2,400 NHS patients died.
Meanwhile a disturbingly similar tragedy is unfolding right here and now – and again the NHS turns a blind eye for fear of negligence lawsuits, and the corrupt medical suppliers hastily reap the profits before the mounting evidence of fraud and corruption forces them back to the dark places that spawned them.
The victims – the frail elderly, the cancer patients, the cystic fibrosis sufferers, have no idea that the C. difficile or MRSA infections they have suffered from were preventable. They are assured that the hospital rooms and equipment have been sterilised by the best technology available – the Deprox – which according to the Hygiene Solutions Ltd. website, “…achieves a log 6 reduction of even the most virulent of organisms.”
The truth is in stark contrast to this glib fabrication; – leaked emails and the testimony of former Hygiene Solutions employees prove that the Deprox units are turned up to their maximum output of RH30 when tested, but in everyday use are turned down to output levels of RH 5 to RH 15 – with directly proportional reductions in H2O2 concentration and germicidal efficacy.
To compound this error, a recent letter published in the Journal of Hospital Infection revealed that most of the tested efficacy of the Deprox process could be attributed to the exceptionally high silver nitrate content of the Deproxin solution – an illegal additive which Hygiene Solutions now claims to have removed.
What residual efficacy remains absent this powerful cytotoxin remains untested and unproven.
The shocking and highly persuasive statistics from the UCLH hospitals, showing a substantial upwards step change in C. difficile rates corresponding exactly with the years of Deprox use, cannot be denied. These are public data sets, and the 75 or so extra infections over this period demand explanation.
We need an inquiry in to the Deprox scandal NOW, while lives can still be saved – not in 30 years time.